12:00 AM
 | 
Oct 22, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Procoralan ivabradine regulatory update

The U.K.'s NICE issued a final appraisal determination (FAD) recommending the use of Procoralan ivabradine from Servier to treat chronic heart failure (CHF) in combination with standard therapy, including...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >